Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTMX | BMY | AMGN | GILD | ILMN |
| Company | Cytomx Thera | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.6100 | 47.39 | 273.45 | 67.47 | 121.97 |
| High | 1.6400 | 47.50 | 274.35 | 67.90 | 122.04 |
| Low | 1.5900 | 45.15 | 268.37 | 66.01 | 117.77 |
| Last | 1.6300 | 45.41 | 268.16 | 65.66 | 117.69 |
| Change | unch | -3.45 | -4.85 | -1.42 | -5.18 |
| % Change | unch | -7.06% | -1.78% | -2.12% | -4.22% |
| Volume | 52,144 | 8,444,982 | 219,911 | 1,293,632 | 124,587 |
| 20-Day Average Volume | 618,915 | 10,908,175 | 2,067,326 | 6,147,293 | 1,471,705 |
| Previous Close | 1.6300 | 48.86 | 273.01 | 67.08 | 122.87 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.9403 | 49.98 | 270.76 | 68.74 | 125.52 |
| 20-Day Raw Stochastic | 0.71% | 2.14% | 35.18% | 6.90% | 12.92% |
| 20-Day Relative Strength | 34.89% | 30.22% | 45.78% | 31.27% | 40.27% |
| Weighted Alpha | -38.02 | -32.97 | +9.74 | -21.80 | -40.06 |
| Today's Opinion | 8% Buy | 88% Sell | 72% Sell | 100% Sell | 88% Sell |
| Previous Opinion | 24% Buy | 88% Sell | 40% Sell | 100% Sell | 88% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 24% Buy | 88% Sell | 24% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.23% since 04/18/24 | -5.70% since 04/18/24 | +2.95% since 04/18/24 | +0.44% since 04/18/24 | +1.87% since 04/18/24 |
| Low | 1.6000 on 04/25/24 | 45.35 on 04/25/24 | 260.68 on 04/19/24 | 66.16 on 04/19/24 | 116.61 on 04/19/24 |
| High | 1.7620 on 04/22/24 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.90 on 04/25/24 | 125.70 on 04/23/24 |
| 1-Month | |||||
| %Chg | -25.00% since 03/25/24 | -12.83% since 03/25/24 | -3.68% since 03/25/24 | -8.45% since 03/25/24 | -11.33% since 03/25/24 |
| Low | 1.6000 on 04/25/24 | 45.35 on 04/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 2.3000 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 140.07 on 03/28/24 |
| 3-Month | |||||
| %Chg | +4.90% since 01/25/24 | -8.19% since 01/25/24 | -12.82% since 01/25/24 | -17.18% since 01/25/24 | -16.73% since 01/25/24 |
| Low | 1.3800 on 02/13/24 | 45.35 on 04/25/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 115.73 on 04/18/24 |
| High | 2.8550 on 03/04/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 80.51 on 01/26/24 | 148.19 on 01/31/24 |
| 6-Month | |||||
| %Chg | +37.18% since 10/25/23 | -19.55% since 10/25/23 | -0.61% since 10/25/23 | -15.23% since 10/25/23 | +4.34% since 10/25/23 |
| Low | 1.0400 on 10/30/23 | 45.35 on 04/25/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 89.00 on 11/10/23 |
| High | 2.8550 on 03/04/24 | 55.29 on 10/26/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 148.19 on 01/31/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 110,403 | 99,027,448 | 146,436,016 | 83,519,768 | 19,567,662 |
| Shares Outstanding, K | 67,732 | 2,026,759 | 536,376 | 1,245,077 | 159,255 |
| Annual Sales | 101,210,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 4,504,000,000 |
| Annual Net Income | -570,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -1,161,000,000 |
| Last Quarter Sales | 26,610,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 1,122,000,000 |
| Last Quarter Net Income | 840,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | -176,000,000 |
| 60-Month Beta | 1.00 | 0.39 | 0.58 | 0.19 | 1.19 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.01 on 03/11/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.14 on 02/08/24 |
| Latest Earnings Date | 05/14/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.53 | 14.67 | 9.97 | 143.06 |